PRTN3 and stroke disorder: Preclinical studies reported that NSPs (NE, CTSG, and PR3) augmented cerebral inflammation, enhanced vascular permeability, and caused tissue damage in experimental stroke models [12–14], which suggests that NSPs are reasonable intervention candidates in IS.